what is glp-1 agonist Top Agonists Balance Weight Loss Efficacy, Safety GLP-1 receptor agonists: Optimising nutritional

Preliminary results from the SURPASS-J-mono study in Japanese patients with T2D who were either therapy nave or on an antidiabetic monotherapy showed a head-to-head comparison of a tirzepatide treatment compared to therapy with the GLP-1RA dulaglutide at a dose of 0.75 mg (54, 76)

241 This mechanism decreases intracellular Ca 2+ concentration, thereby inhibiting glucagon secretion

Results Eleven cardiovascular outcome trials comprising 91,490 participants were included, with a mean follow-up of 2.7 years

Semaglutide (weekly injection) is the most widely used with strong weight loss data

SURPASS-AP-combo, respective clinical trial registration numbers NCT04537923, NCT04255433, NCT03861052, NCT03861039, NCT04093752) are not completed yet

Moreover, there was no significant change in urine SI with respect to calcium phosphate (0.740.99 to 0.630.58) or uric acid (1.091.07 to 1.001.12) in the GLP group (Table 3)